Teva, Purdue Put OxyContin Litigation Behind Them
Israel-based Teva was given a full release from the litigation and Stamford, Conn.-based pharmaceutical Purdue will not seek damages for past infringement, the companies said.
Under the terms of the settlement agreement, Teva will cease selling oxycodone products at an unspecified future date. Teva said that it anticipates sales of its...
To view the full article, register now.